Literature DB >> 17092587

Endothelial dysfunction and restenosis following percutaneous coronary intervention.

Panuratn Thanyasiri1, Krishna Kathir, David S Celermajer, Mark R Adams.   

Abstract

BACKGROUND: Restenosis remains an important limitation of PCI. Although local factors such as small vessel diameter and systemic factors such as diabetes explain some of its incidence, it nevertheless also occurs in low-risk patients. We hypothesize that endothelial dysfunction may be an independent risk factor in some of these cases.
METHODS: 20 patients who had previously undergone PCI were studied at cardiac catheterization (10 with restenotic lesions were matched to 10 without restenosis). Infusion of multiple concentrations of acetylcholine (ACh) and nitroglycerine (GTN) were made via a 3F infusion catheter into the target artery. Following infusion, changes in diameter of segments proximal and distal to the PCI site were measured.
RESULTS: There was a significant impairment in endothelium-dependent dilatation at the maximal dose of acetylcholine in those with restenosis compared to those without restenosis, both proximal and distal to the stented area (proximal; 11.5+/-7.0% versus -20.9+/-9.0% p<0.001, distal; 12.0+/-3.1% versus -17.8+/-8.1% p<0.001), but there was no difference in the response to GTN. There was a significant correlation between the endothelium-dependent dilatation response and the percent restenosis (r=-0.65, p=0.003).
CONCLUSIONS: Coronary endothelium-dependent dilatation is reduced in subjects with restenosis in arterial segments separate from the stented lesion. This supports a hypothesis that endothelial dysfunction contributes to the development of restenosis, following percutaneous coronary intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092587     DOI: 10.1016/j.ijcard.2006.08.015

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.

Authors:  Teruo Inoue; Kevin Croce; Toshifumi Morooka; Masashi Sakuma; Koichi Node; Daniel I Simon
Journal:  JACC Cardiovasc Interv       Date:  2011-10       Impact factor: 11.195

2.  Stent thrombosis: understanding and managing a critical problem.

Authors:  Julio F Marchini; Andre Manica; Kevin Croce
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02

3.  Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after percutaneous coronary intervention.

Authors:  Shu-qin Ying; Mei-xiang Xiang; Lu Fang; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2010-08       Impact factor: 3.066

4.  Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Xin Zhang; Xiang-Yang Zhu; Hui Tang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Circ Cardiovasc Interv       Date:  2012-10-09       Impact factor: 6.546

5.  Angiotensin type 1 receptor A1166C gene polymorphism is associated with endothelial dysfunction and in-stent restenosis after percutaneous coronary intervention.

Authors:  Yu Li; Fang Chen; Xiaoling Zhang; Yuechun Gao; Changyan Wu; Haiyan Li; Yuchen Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

6.  Relationship between endothelial vasomotor function and strut coverage after implantation of drug-eluting stent assessed by optical coherence tomography.

Authors:  Hoyoun Won; Jung-Sun Kim; Dong-Ho Shin; Byeong-Keuk Kim; Young-Guk Ko; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Int J Cardiovasc Imaging       Date:  2013-11-13       Impact factor: 2.357

7.  Plasma asymmetric dimethylarginine predicts restenosis after coronary angioplasty.

Authors:  Arkadiusz Derkacz; Marcin Protasiewicz; Rafał Poręba; Adrian Doroszko; Małgorzata Poręba; Jolanta Antonowicz-Juchniewicz; Ryszard Andrzejak; Andrzej Szuba
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

8.  Combination treatment with asiaticoside and rapamycin: A new hope for in-stent restenosis.

Authors:  Tian Guo; Ming Fang; Dadong Zhang; Xinming Li
Journal:  Exp Ther Med       Date:  2013-06-13       Impact factor: 2.447

Review 9.  Reperfusing the myocardium - a damocles Sword.

Authors:  V K Shah; K K Shalia
Journal:  Indian Heart J       Date:  2017-11-08

10.  Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting Model.

Authors:  Rayyan Hemetsberger; Serdar Farhan; Dominika Lukovic; Katrin Zlabinger; Judit Hajagos-Toth; Judit Bota; Hector M Garcia-Garcia; Cihan Ay; Eslam Samaha; Robert Gaspar; Rita Garamvölgyi; Kurt Huber; Mariann Gyöngyösi; Andreas Spannbauer
Journal:  Front Cardiovasc Med       Date:  2021-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.